SNORD68: A Potential Drug Target for Neurological Disorders (G606500)

Target Name: SNORD68

NCBI ID: G606500

SNORD68

Other Name(s): HBII-202 | Small nucleolar RNA, C/D box 68 | small nucleolar RNA, C/D box 68

SNORD68: A Potential Drug Target for Neurological Disorders

SNORD68 (HBII-202) is a protein that is expressed in the brain and is involved in the regulation of various cellular processes. It is a key regulator of the microtubules, which are the structural elements that give cells their shape and movement. SNORD68 is also involved in the regulation of the actinin filaments, which are proteins that help to keep cells standing and organized.

Recent studies have suggested that SNORD68 may be a drug target (or biomarker) for various neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and depression. This is because SNORD68 is involved in the regulation of important cellular processes that are disrupted in these disorders.

One of the mechanisms by which SNORD68 is involved in the regulation of microtubules is through its role in the regulation of the stability of the microtubules. Microtubules are made up of several protein building blocks that are arranged in a specific sequence to give the cell its shape and movement. SNORD68 is involved in the regulation of the stability of these building blocks, which allows the cell to maintain its shape and move freely.

Mutations in the SNORD68 gene have been shown to cause a variety of neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and depression. These mutations have been shown to disrupt the regulation of microtubules, leading to the misfunction of the cell.

Another mechanism by which SNORD68 is involved in the regulation of microtubules is through its role in the regulation of the actinin filaments. Actinin filaments are a type of protein that help to keep cells standing and organized. SNORD68 is involved in the regulation of the length and stability of these filaments, which allows the cell to maintain its shape and organization.

Mutations in the SNORD68 gene have also been shown to cause the regulation of actinin filaments to be disrupted, leading to the misfunction of the cell. This suggests that SNORD68 may be a useful drug target (or biomarker) for the treatment of disorders that are characterized by the disruption of microtubules and actinin filaments.

In conclusion, SNORD68 is a protein that is involved in the regulation of various cellular processes, including the regulation of microtubules and actinin filaments. Mutations in the SNORD68 gene have been shown to cause a variety of neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and depression. These mutations have disrupted the regulation of microtubules and actinin filaments, leading to the misfunction of the cell. Therefore, SNORD68 may be a drug target (or biomarker) for the treatment of these disorders.

Protein Name: Small Nucleolar RNA, C/D Box 68

The "SNORD68 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORD68 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets